Using Neuroscience to Advance Therapeutics of Pediatric Anxiety
The Child Mind Institute Visiting Professor Lecture Series:
In this series, we invite leaders in the field of child and adolescent mental health and learning disorders to talk about the latest research and treatment protocols. These experts share their findings and expertise on a broad range of topics from anxiety and depression to temper outbursts and the effectiveness of parent-based treatment. Lectures are also available via live webinar online. We offer continuing medical education credits for medical professionals. For more events like this please go to our Visiting Professor Lecture Series page.
Presenter: Daniel Pine, MD
Dr. Daniel Pine is chief of the Section on Development and Affective Neuroscience in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 500 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and president of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.
Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.
Planner and Speaker’s Disclosures:
Harold Koplewicz, MD, Ron Steingard, MD, and John Q. Young, MD, have nothing to disclose. Daniel Pine, MD, has nothing to disclose.
Recognition of Program Support:
An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.